))
PTX partners with the US's largest cancer centre to continue development of personalised cancer treatment
Archived series ("Inactive feed" status)
When?
This feed was archived on August 05, 2024 06:12 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 340612486 series 2656033
Content provided by Stockhead. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stockhead or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX).
61 episodes
Share
